1. World Health Organization . How to develop and implement a national drug policy. 2nd edn. World Health Organization, 2001. Available: https://apps.who.int/iris/handle/10665/42423
2. US food and drug administration: priority review. n.d. Available: https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/priority-review
3. US department of health and human services, food and drug administration, center for drug evaluation and research (CDER). In: Center for Biologics Evaluation and Research (CBER). Guidance for Industry. Expedited Programs for Serious Conditions- Drugs and Biologics. Available: https://www.fda.gov/files/drugs/published/Expedited-Programs-for-Serious-Conditions-Drugs-and-Biologics.pdf
4. US food and drug administration: development and approval process. n.d. Available: https://www.fda.gov/drugs/developmentapprovalprocess/default.htm
5. US food and drug administration: accelerated approval. n.d. Available: https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm